Liabilities and Equity of Merck & Co., Inc. from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Merck & Co., Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • Merck & Co., Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $129,546,000,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Merck & Co., Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $129,546,000,000 +$12,014,000,000 +10% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $117,523,000,000 +$4,893,000,000 +4.3% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $115,122,000,000 +$9,273,000,000 +8.8% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $117,106,000,000 +$10,431,000,000 +9.8% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $117,532,000,000 +$10,805,000,000 +10% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $112,630,000,000 +$8,161,000,000 +7.8% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $105,849,000,000 -$1,947,000,000 -1.8% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $106,675,000,000 -$2,485,000,000 -2.3% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $106,727,000,000 -$354,000,000 -0.33% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $104,469,000,000 -$2,626,000,000 -2.5% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $107,796,000,000 +$1,128,000,000 +1.1% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $109,160,000,000 +$3,466,000,000 +3.3% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $107,081,000,000 +$13,587,000,000 +15% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $107,095,000,000 +$16,407,000,000 +18% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $106,668,000,000 +$15,821,000,000 +17% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $105,694,000,000 +$14,106,000,000 +15% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 $93,494,000,000 +$3,694,000,000 +4.1% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $90,688,000,000 +$73,000,000 +0.08% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $90,847,000,000 +$5,934,000,000 +7% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $91,588,000,000 +$7,191,000,000 +8.5% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $89,800,000,000 +$6,469,000,000 +7.8% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $90,615,000,000 +$6,650,000,000 +7.9% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $84,913,000,000 +$2,559,000,000 +3.1% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $84,397,000,000 +$1,760,000,000 +2.1% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $83,331,000,000 -$1,799,000,000 -2.1% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $83,965,000,000 -$1,075,000,000 -1.3% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $82,354,000,000 -$3,687,000,000 -4.3% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $82,637,000,000 -$5,235,000,000 -6% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $85,130,000,000 -$6,546,000,000 -7.1% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $85,040,000,000 -$7,764,000,000 -8.4% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $86,041,000,000 -$10,520,000,000 -11% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $87,872,000,000 -$7,505,000,000 -7.9% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $91,676,000,000 -$6,659,000,000 -6.8% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $92,804,000,000 -$3,671,000,000 -3.8% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $96,561,000,000 -$2,194,000,000 -2.2% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $95,377,000,000 -$6,300,000,000 -6.2% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $98,335,000,000 -$2,897,000,000 -2.9% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 $96,475,000,000 -$6,107,000,000 -6% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 $98,755,000,000 -$9,590,000,000 -8.9% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 $101,677,000,000 +$3,510,000,000 +3.6% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $101,232,000,000 -$576,000,000 -0.57% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $102,582,000,000 +$4,722,000,000 +4.8% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $108,345,000,000 -$115,000,000 -0.11% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $98,167,000,000 -$7,478,000,000 -7.1% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 $101,808,000,000 -$4,611,000,000 -4.3% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 $97,860,000,000 -$9,016,000,000 -8.4% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $108,460,000,000 +$2,260,000,000 +2.1% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $105,645,000,000 -$487,000,000 -0.46% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q3 2013 $106,419,000,000 +$118,000,000 +0.11% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $106,876,000,000 +$1,351,000,000 +1.3% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 $106,200,000,000 +$691,000,000 +0.66% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $106,132,000,000 +$1,004,000,000 +0.96% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q3 2012 $106,301,000,000 -$233,000,000 -0.22% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $105,525,000,000 -$670,000,000 -0.63% 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 $105,509,000,000 -$356,000,000 -0.34% 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q4 2011 $105,128,000,000 -$653,000,000 -0.62% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q3 2011 $106,534,000,000 -$1,306,100,000 -1.2% 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $106,195,000,000 +$24,500,000 +0.02% 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q1 2011 $105,865,000,000 -$5,728,800,000 -5.1% 31 Mar 2011 10-Q 09 May 2011 2011 Q1
Q4 2010 $105,781,000,000 31 Dec 2010 10-K 28 Feb 2012 2011 FY
Q3 2010 $107,840,100,000 30 Sep 2010 10-Q 08 Nov 2010 2010 Q3
Q2 2010 $106,170,500,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
Q1 2010 $111,593,800,000 31 Mar 2010 10-Q 07 May 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.